Scientific Truth and the Courts

As a nonscientist, I am not qualified to question The New York Times' editorial conclusion that there is no association between spermicides and birth defects (The Scientist, January 26, 1987. P. 13). But I do question its conclusion that "both law and science seek after truth." Until all those involved in the resolution of problems such as in Wells v. Ortho recognize that law does not necessarily seek truth—except in some very long-range, societal sense not relevant to the short-term needs

Written byMilton Wessel
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Our legal process seeks to make it possible for people to live together on this planet in harmony. It does so by taking into account a great number of different and sometimes conflicting concerns, of which truth is only one. Often the process actually excludes important evidence in order to achieve the desired result, which it characterizes as "justice," "fairness" or "equity"—not "truth." Whether or not the Miranda rule is modified as result of the current attack on it, all are agreed that a court may not consider even the most important evidence such as a confession if it has been obtained through police brutality or other misconduct such as entrapment. Similarly, confidential communications between a client and his attorney are privileged from disclosure in court no matter how relevant, and a statute of frauds rejects evidence not in proper written form.

For the most part, our legal process achieves ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies